Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Reexamination Certificate
2005-01-07
2008-10-14
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
C424S642000, C514S494000, C514S629000, C514S635000, C514S643000, C514S739000
Reexamination Certificate
active
07435429
ABSTRACT:
The present invention provides for compositions and methods that may offer protection from irritants, as well as antimicrobial protection. Preferred embodiments of the invention include topical antimicrobial compositions comprising two or more water-soluble zinc salts in low concentrations.
REFERENCES:
patent: 3485915 (1969-12-01), Gerstein et al.
patent: 4478853 (1984-10-01), Chaussee
patent: 4853978 (1989-08-01), Stockum
patent: 4889844 (1989-12-01), Silvetti, Sr. et al.
patent: 4956170 (1990-09-01), Lee et al.
patent: 4963591 (1990-10-01), Fourman et al.
patent: 5059416 (1991-10-01), Cherukuri et al.
patent: 5116602 (1992-05-01), Robinson et al.
patent: 5133090 (1992-07-01), Modak et al.
patent: 5208031 (1993-05-01), Kelly
patent: 5357636 (1994-10-01), Dresdner, Jr. et al.
patent: 5403864 (1995-04-01), Bruch et al.
patent: 5447930 (1995-09-01), Nayak
patent: 5516510 (1996-05-01), Beilfuss et al.
patent: 5591442 (1997-01-01), Diehl et al.
patent: 5624675 (1997-04-01), Kelly
patent: 5705532 (1998-01-01), Modak et al.
patent: 5708023 (1998-01-01), Modak et al.
patent: 5753270 (1998-05-01), Beauchamp et al.
patent: 5776430 (1998-07-01), Osborne et al.
patent: 5885562 (1999-03-01), Lowry et al.
patent: 5951993 (1999-09-01), Scholz et al.
patent: 5965610 (1999-10-01), Modak et al.
patent: 5980477 (1999-11-01), Kelly
patent: 5985918 (1999-11-01), Modak et al.
patent: 6022551 (2000-02-01), Jampani et al.
patent: 6037386 (2000-03-01), Modak et al.
patent: 6107261 (2000-08-01), Taylor et al.
patent: 6136771 (2000-10-01), Taylor et al.
patent: 6187327 (2001-02-01), Stack
patent: 6204230 (2001-03-01), Taylor et al.
patent: 6321750 (2001-11-01), Kelly
patent: 6352701 (2002-03-01), Scholz et al.
patent: 6387357 (2002-05-01), Chopra et al.
patent: 6426062 (2002-07-01), Chopra et al.
patent: 6723689 (2004-04-01), Hoang et al.
patent: 2003/0152644 (2003-08-01), Modak et al.
patent: 2005/0019431 (2005-01-01), Modak et al.
patent: 2006/0141017 (2006-06-01), Kling et al.
patent: 402078 (1992-09-01), None
patent: 0604848 (1994-07-01), None
patent: WO9903463 (1999-01-01), None
patent: WO99/38505 (1999-05-01), None
patent: WO9963816 (1999-12-01), None
patent: 03034994 (2003-05-01), None
patent: 03003896 (2003-08-01), None
patent: WO 03/066001 (2003-08-01), None
Cimiotti et al., Adverse reactions associated with an alcohol-based hand antiseptic among nurses in a neonatal intensive care unit.Am. J. Infect. Control2003:131:43-48.
Bleasel et al., Allergic contact dermatitis following exposure to essential oils.Australian Journal of Dermatology2002;43:211-213.
Vilaplana et al., Contact dermatitis from the essential oil of tangerine in fragrances.Contact Dermatitis2002;46:108.
Larsen et al., Fragrance contact dermatitis: a worldwide multicenter investigation (Part II).Contact Dermatitis2001;44:344-346.
Nair B. Final report on the safety assessment of Mentha Piperita (Peppermint) oil, Mentha Piperita (Peppermint) Leaf extract, and Mentha Piperita (Peppermint) leaf and Mentha Piperita (Peppermint) water.International Journal of Toxicology2001;20(Suppl 3):61-73.
Wohrl et al., The significance of fragrance mix, balsam of Peru, colophony and propolis as screening tools in the detection of fragrance allergy.British Journal of Dermatology2001;145(2):268-273.
Sugiura., 2000, “Results of patch testing with lavender oils in Japan” Contact Dermatitis 43:157-160.Contact Dermatitis2000;43:157-160.
De Groot et al., Adverse reactions to fragrances: a clinical review.Contact Dermatitis1997;36:57-86.
Bush et al., 1986, “Pig skin as test substrate for evaluating topical antimicrobial activity” J Clin Microbiol 24:343-348.
Meyer et al., 1978, “The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig.” Curr. Problem Dermatol 7:39-52.
Modak et al., 2005, A topical cream containing a zinc gel (allergy guard) as a prophylactic against latex glove-related contact dermatitis. Dermatitis. 16(1):22-7.
Modak SM, et al., A Topical Zinc Gluconate Gel Composition for the Prevention of latex/Starch Glove Related Allergic Reactions: Pilot Study in Volunteers. In: Programs and Abstracts of the 37thInterscience Conference on Antimicrobial Agents and Chemotherapy, Toronto: 1997; American Society for Microbiology Washington DC. Abstract J -52.
Goodman and Gilman's The Pharmacological Basis of Therapeutics (Goodman Gilman A, Rall TW, Nies AS, Taylor P, ed. (Pergamon Press; Elmsford, N.Y.: 1990).
Lansdown, “Interspecies variations in reponse to topical application of selected zinc compounds,” Food Chem Toxicol. Jan. 1991;29(1):57-64.
Rosenthal, S.L.; Effect of Medicaments on the Motility of the Oral Flora with Special Reference to the Treatment of Vincent's Infection; II. Journal of Dental Research; 1943; vol. 22, pp. 491-494.
Caraos Lauserpina
Gaonkar Trupti
Geraldo Ingrid
Modak Shanta M.
Shintre Milind
Baker & Botts LLP
Henley III Raymond J.
Trustees of Columbia University in the City of New York
LandOfFree
Zinc salt compositions for the prevention of dermal and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Zinc salt compositions for the prevention of dermal and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Zinc salt compositions for the prevention of dermal and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4012242